相关实验视频
Updated: Jan 11, 2026
07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
981
类风湿性关节炎:生物标志物和最新的突破
Meilang Xue1, Hui Wang1, Frida Campos1
1Sutton Arthritis Research Laboratory, The Australian Arthritis and Autoimmune Biobank Collaborative (A3BC), Sydney Musculoskeletal Health, Kolling Institute, Faculty of Medicine and Health, The University of Sydney at Royal North Shore Hospital, St Leonards, NSW 2065, Australia.
International journal of molecular sciences
|November 13, 2025
概括
发现类风湿性关节炎 (RA) 的新生物标志物正在彻底改变早期诊断和个性化治疗. 多基因和微生物组研究为了解和管理这种复杂的自身免疫性疾病提供了强大的工具.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 生物标志物发现发现
背景情况:
- 类风湿性关节炎 (RA) 是一种异质的自身免疫性疾病,进展不可预测,使早期诊断和治疗复杂化.
- 目前的RA诊断和治疗策略面临疾病变异性带来的挑战.
研究的目的:
- 审查近期在类风湿性关节炎生物标志物发现方面的进展.
- 突出多omics技术和synovial微环境分析对RA研究的影响.
- 强调新型生物标志物在早期检测,监测和个性化治疗方面的潜力.
主要方法:
- 关于在类风湿性关节炎中发现生物标志物的最新文献的综述.
- 强调多omics技术,包括基因组学,转录组学,蛋白质组学和代谢组学.
- 结合肠道微生物组研究和突微环境分析.
主要成果:
- 基因组学和转录组学已经确定了与RA易感性,进展和治疗反应相关的遗传变异和表达特征.
- 蛋白质学和代谢学揭示了与RA炎症和关节损伤相关的分子模式.
- 肠道微生物群显示出作为RA诊断和免疫调节的非侵入性生物标志物的潜力.
- 集成的多omics数据和突造型使得全面的分子肖像和空间分辨的生物标志物成为可能.
结论:
- 多主题技术和突造型正在改变RA护理.
- 这些创新促进了早期检测,改善了疾病监测和个人化RA治疗策略.
- 开发全面的生物标记面板有望优化类风湿性关节炎患者的治疗结果.
相关概念视频
01:11Genome-wide Association Studies-GWAS
15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.3K
01:20The JAK-STAT Signaling Pathway
11.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.9K
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
470
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
470
01:23Rheumatic Heart Disease I: Introduction
415
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
415
01:21Rheumatic Heart Disease III: Medical Management
272
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
272